EVEREST MED: CBC Group Boosts Stake with HK$20.00 Million On-Market Purchase of 690,000 Shares
Bulletin Express
Jun 04
Everest Medicines Limited (EVEREST MED) announced that CBC Group, a substantial shareholder, acquired 690,000 ordinary shares on 3 June 2026 through on-market transactions, paying a total of HK$20.00 million at an average price of HK$28.93 per share.
The purchase was disclosed to the Board by non-executive director and honorary chairman Wei Fu, who is also a substantial shareholder. According to the filing, the additional investment reflects confidence in the company’s long-term prospects.
CBC Group and Wei Fu indicated that further share purchases may be considered, subject to regulatory compliance.
The company reiterated that shareholders and potential investors should exercise caution when trading its securities.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.